Rapigen
Manufacturer and developer of in-vitro diagnostic kits and reagents, with expertise in rapid (point-of-care) diagnostics and molecular PCR-based diagnostics. Offers end-to-end activities from raw material design and assay development to high-volume manufacturing and global distribution, and supports OEM customization. Exports products to multiple countries and has documented national authorizations and export approvals.
Industries
Nr. of Employees
medium (51-250)
Products
Rapid diagnostic tests (RDTs)
Point-of-care rapid immunoassay tests, including COVID-19 related self-tests and other infectious disease RDTs.
Molecular diagnostic kits
PCR-based molecular diagnostic products and related reagents and consumables for laboratory and point-of-care use.
Veterinary diagnostic products
Diagnostic kits tailored for veterinary and animal health applications.
Rapid diagnostic tests (RDTs)
Point-of-care rapid immunoassay tests, including COVID-19 related self-tests and other infectious disease RDTs.
Molecular diagnostic kits
PCR-based molecular diagnostic products and related reagents and consumables for laboratory and point-of-care use.
Veterinary diagnostic products
Diagnostic kits tailored for veterinary and animal health applications.
Services
OEM manufacturing and customization
Custom manufacturing and private-label production of diagnostic kits and reagents tailored to partner specifications.
Technical and commercial contact/support
Contact center support for inquiries and regional sales/technical liaison (separate contact pages for USA and other countries).
OEM manufacturing and customization
Custom manufacturing and private-label production of diagnostic kits and reagents tailored to partner specifications.
Technical and commercial contact/support
Contact center support for inquiries and regional sales/technical liaison (separate contact pages for USA and other countries).
Expertise Areas
- In-vitro diagnostics
- Rapid diagnostic tests (point-of-care)
- Molecular diagnostics (PCR-based)
- Immunodiagnostics and reagent development
Key Technologies
- Lateral flow immunoassays
- Gold nanoparticle labeling for lateral flow assays
- PCR-based molecular assays
- Point-of-care cartridge systems